Perfluorohexyloctane

Tier C — Watch / trade

Novaliq Gmbh

Originator

2023

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：Lipid

Brand：NovaTears, Heng Qin, Miebo

Indications (approved)：Dry eye disease, Dry eye syndrome

Regional status

Approved

2023-05-18

China

Approved

2025-06-30

Japan

Factories producing this API1

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

1 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 4 · Total yield 10.4g(Perfluorohexyloctane (Free))

Perfluorohexyloctane-001106-99-0Perfluorohexyloctane-002—Perfluorohexyloctane-003—Perfluorohexyloctane-004—Perfluorohexyloctane-005—API · Perfluorohexyloctane

Code	CAS No.	Intermediate
Perfluorohexyloctane-001	106-99-0	1,3-Butadiene
Perfluorohexyloctane-002	-	1-Methoxy-2,7-octadiene
Perfluorohexyloctane-003	-	1-Methoxyoctane
Perfluorohexyloctane-004	-	1-Octene
Perfluorohexyloctane-005	-	1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluoro-6-iodohexane

OptimisedRoute 2Steps 3 · Total yield 120.2g(Perfluorohexyloctane (Free))

Perfluorohexyloctane-006—Perfluorohexyloctane-007—Perfluorohexyloctane-008638-45-9Perfluorohexyloctane-009—API · Perfluorohexyloctane

Code	CAS No.	Intermediate
Perfluorohexyloctane-006	-	1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluoro-8-iodooctane
Perfluorohexyloctane-007	-	2-(Perfluorohexyl)ethylmagnesium chloride
Perfluorohexyloctane-008	638-45-9	1-Iodohexane
Perfluorohexyloctane-009	-	Chlorido(hexyl)magnesium

Frequently asked questions

What are the approved indications of Perfluorohexyloctane?

Approved indications include: Dry eye disease, Dry eye syndrome.

When does the Perfluorohexyloctane patent expire?

No public expiry year is available for Perfluorohexyloctane yet; this page updates once verified.

How many synthesis routes are recorded for Perfluorohexyloctane?

2 synthesis routes are recorded; the shortest is 3 steps with 120.2g(Perfluorohexyloctane (Free)) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Perfluorohexyloctane intermediates?

All intermediates in Perfluorohexyloctane routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Perfluorohexyloctane intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29